Sort
15,842 grants matching “pancreatic cancer”
Directing the metabolic fate of CAR T cells
$432,308Carl H. June · University Of Pennsylvania · R01 · FY2018 · CA
Directing the metabolic fate of CAR T cells
$432,308Carl H. June · University Of Pennsylvania · R01 · FY2021 · CA
MULTIPLEX CHEMICAL TAGS FOR HIGH-THROUGHPUT GLYCAN AND GLYCOPEPTIDE QUANTITATION AND CHARACTERIZATION
$432,228Lingjun Li · University Of Wisconsin-Madison · U01 · FY2020 · CA
Targeting aberrant enhancer landscapes in pancreatic cancer
$432,000Christopher Vakoc · Cold Spring Harbor Laboratory · R01 · FY2024 · CA
Targeting aberrant enhancer landscapes in pancreatic cancer
$432,000Christopher Vakoc · Cold Spring Harbor Laboratory · R01 · FY2025 · CA
Mechanisms of immunotherapy response and resistance in pancreatic ductal adenocarcinoma
$431,993Ingunn Margarete Stromnes · University Of Minnesota · R01 · FY2025 · CA
Monitoring Listeria in vivo using 18FDG and PET scan
$431,970Claudia Gravekamp · Albert Einstein College Of Medicine · R21 · FY2024 · CA
Systematic characterization of cancer variants using single-cell functional genomics
$431,914Thomas Maxwell Norman · Sloan-Kettering Inst Can Research · R33 · FY2023 · CA
In situ protein analysis of laser dissected cell ensembles
$431,750Alexandra Ros · Arizona State University-Tempe Campus · R21 · FY2020 · AG
Targeting pancreatic cancer's metabolic addiction to HuR
$431,688Jordan M Winter · Case Western Reserve University · R37 · FY2023 · CA
Targeting HMGA1 Tumor-Stromal Networks in Pancreatic Carcinogenesis
$431,561Linda M S Resar · Johns Hopkins University · R01 · FY2024 · CA
CHARM 2: Chemotherapy for ablation and resolution of mucinous pancreatic cysts: a prospective, randomized, double-blind, multi-center clinical trial
$431,536Matthew T. Moyer · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2020 · CA
Development of Methods for Cancer Biomarker Detection
$431,348Wistar Institute · R33 · FY2002 · CA
P-4: Direct Delivery of Immune-modulating Therapies to the Pancreatic Tumor Site
$431,346Pinku Mukherjee · Mayo Clinic Rochester · P50 · FY2012 · CA
Mechanisms of diabetic amyloid formation via 2D IR spectroscopy
$431,169Martin T Zanni · University Of Wisconsin-Madison · R01 · FY2023 · DK
Mechanisms of immunotherapy response and resistance in pancreatic ductal adenocarcinoma
$431,094Ingunn Margarete Stromnes · University Of Minnesota · R01 · FY2021 · CA
Thrombin-dependent mechanisms of pancreatic ductal adenocarcinoma disease
$431,066Matthew J. Flick · Cincinnati Childrens Hosp Med Ctr · R01 · FY2017 · CA
Clinical protocols for the treatment of gastrointestinal cancer
$431,019Tim Greten · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Development and application of asymmetric-flow field-flow (AF4) technology in fractionation and characterization of exosome subpopulations and novel nanoveiscles in pancreatic cancer model
$430,996David Charles Lyden · Weill Medical Coll Of Cornell Univ · R01 · FY2018 · CA
Exosomes as Endocrine Signaling Molecules in Cancer Cachexia
$430,995Daniel L Marks · Oregon Health & Science University · R01 · FY2022 · CA
Understanding and targeting mutant splicing factors in pancreatic cancer
$430,974Luisa Escobar Hoyos · Yale University · R01 · FY2022 · CA
Southern California Research Center for ALPD and Cirrhosis
$430,973Hidekazu Tsukamoto · University Of Southern California · P50 · FY2024 · AA
Pharmacodynamics of Gemcitabine by MRS in Pancreatic CA
$430,866New York University School Of Medicine · R01 · FY2005 · CA
Molecular Basis of ME2-mediated Tumor Suppression in Pancreatic Cancer
$430,604Pankaj Kumar Singh · University Of Oklahoma Hlth Sciences Ctr · R01 · FY2025 · CA
Molecular Basis of ME2-mediated Tumor Suppression in Pancreatic Cancer
$430,604Pankaj Kumar Singh · University Of Oklahoma Hlth Sciences Ctr · R01 · FY2022 · CA